Antipsychotic drug actions on gene modulation and signaling mechanisms.
about
Aripiprazole: from pharmacological profile to clinical useThe tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medicationsAltered serine/threonine kinase activity in schizophreniaEffects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS StudiesGWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophreniaAlteration of imprinted Dlk1-Dio3 miRNA cluster expression in the entorhinal cortex induced by maternal immune activation and adolescent cannabinoid exposure.Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia.Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.Dopamine agonist signalling in the hypothalamus of female rats is independent of calcium-dependent kinasesKai-Xin-San, a traditional Chinese medicine formulation, exerts antidepressive and neuroprotective effects by promoting pCREB upstream pathwaysGSK-3β activity and hyperdopamine-dependent behaviorsSerotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins.The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia.MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.Elevated dopamine D2 receptor in prefrontal cortex of CUMS rats is associated with downregulated cAMP-independent signaling pathway.Neuregulin 1-alpha regulates phosphorylation, acetylation, and alternative splicing in lymphoblastoid cells.The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target.Altered expression of schizophrenia-related genes in mice lacking mGlu5 receptors.Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide(25-35), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death.Abnormalities of signal transduction networks in chronic schizophrenia.Neurite outgrowth mediated by the heat shock protein Hsp90α: a novel target for the antipsychotic drug aripiprazole.Transcriptomic analysis in a Drosophila model identifies previously implicated and novel pathways in the therapeutic mechanism in neuropsychiatric disordersPregnenolone blocks cannabinoid-induced acute psychotic-like states in mice.Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication.Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid.Prunella vulgaris attenuates prepulse inhibition deficit and attention disruption induced by MK-801 in mice.Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats.Chronic administration of haloperidol and clozapine induces differential effects on the expression of Arc and c-Fos in rat brain.Role of MKP-1 (DUSP1) in clozapine-induced effects on the ERK1/2 signaling pathway in the rat frontal cortex.Lack of association between 71 variations located in candidate genes and response to acute haloperidol treatment.Antipsychotic Induced Alteration of Growth and Proteome of Rat Neural Stem Cells
P2860
Q26778312-157DB12E-1F49-4368-9D73-982F2FCF769AQ28270728-78F63D22-87F4-485B-825A-19617AE9355DQ30409979-267A96E5-9D1F-42ED-9B3C-10D79A58B2C6Q33611412-FFC9886E-6FAA-4AAF-B70F-CF6302EA95C4Q33691275-6F0DBEB0-D354-41E1-9B1D-09976D24B42DQ34370550-557E8481-4BAD-40B6-88C5-06B763415045Q35417493-FCFC1F53-B2B9-4FB0-BE96-CDA954A05348Q35760215-19D38384-8477-4B7B-84EF-1EB5D1F3583AQ36848198-A28B73A2-0398-4BB5-93F5-29F523C47099Q37406564-A2C5CA3B-6A3B-4899-A3F6-7239E19F0657Q37781424-F59014D2-4B42-4994-801F-4C3156465DEBQ38062443-FB80F556-5255-4811-9A6E-56582B69D942Q38120295-48D3F0ED-0B0F-4F6E-BE49-C6D1C34F9A7AQ38267957-854CDC48-AA9B-4773-A227-40706EC354D1Q38313046-5E4E3F30-8171-43F0-8C81-F3494CA736A4Q38483371-BED2DBA6-64E0-4494-9E9F-B2C190274142Q38592139-2E614892-64BD-4A81-8B67-0E3C0108073CQ38831859-0B9D84E7-D45D-485F-82AC-FCF99F460A9DQ39434394-133E8D31-289F-4980-9752-28F4C483CAC4Q39552320-5013BEE1-0395-4F59-AFAF-4E0B93EE189EQ41195184-3A6D5035-3E3C-4720-9602-DE3CE3F37365Q41828115-3A654B5D-A929-4C41-AB55-C3595F2006FEQ41842199-30E59D4C-95B3-4015-B50D-D39B477F564EQ41994722-5CAF3511-87E9-4151-AF59-23ED7B79D7BFQ44401758-58CB8BEB-0308-4F85-96A9-955A6C645A5FQ44403456-DDDC8437-9C57-41AC-ADF7-529E3E3EB50FQ48194937-760C7C48-7DCF-4D31-9E3A-4C3E581593DEQ48288448-FC813C0B-B51E-482D-890B-C3C248FD9855Q48681485-D6F6E221-786C-42D2-BF41-9BCF561E4F43Q50903681-C5A9AE62-703A-4064-8561-8B4965D16F3AQ51828618-76C1BDE2-F6D4-4DBC-AA55-5A0770245C23Q57253280-13603C61-2262-4822-A871-FBE378067B26
P2860
Antipsychotic drug actions on gene modulation and signaling mechanisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antipsychotic drug actions on gene modulation and signaling mechanisms.
@en
Antipsychotic drug actions on gene modulation and signaling mechanisms.
@nl
type
label
Antipsychotic drug actions on gene modulation and signaling mechanisms.
@en
Antipsychotic drug actions on gene modulation and signaling mechanisms.
@nl
prefLabel
Antipsychotic drug actions on gene modulation and signaling mechanisms.
@en
Antipsychotic drug actions on gene modulation and signaling mechanisms.
@nl
P50
P1476
Antipsychotic drug actions on gene modulation and signaling mechanisms.
@en
P2093
Giorgio Racagni
P356
10.1016/J.PHARMTHERA.2009.06.001
P577
2009-06-21T00:00:00Z